Pesquisar
Precipio Inc
PRPOAdicionar à lista de desejos
23.970USD
+0.510+2.17%
Fechamento 08-07 16:00（ET）Cotações atrasadas em 15 min
42.75MValor de mercado
PerdaP/L TTM
Mais detalhes de Precipio Inc Empresa
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Precipio Inc Perfil
Código da empresaPRPO
Nome da EmpresaPrecipio Inc
Data de listagemJul 18, 2000
CEODanieli (Ilan S)
Número de funcionários54
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 18
Endereço4 Science Park
CidadeNEW HAVEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06511
Telefone12037877888
Sitehttps://www.precipiodx.com/
Código da empresaPRPO
Data de listagemJul 18, 2000
CEODanieli (Ilan S)
Executivos da empresa Precipio Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
Mr. Ronald A. (Ron) Andrews, Jr.
Mr. Ronald A. (Ron) Andrews, Jr.
Independent Director
Independent Director
--
--
Dr. Ayman A. Mohamed, M.D.
Dr. Ayman A. Mohamed, M.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Matthew Gage
Mr. Matthew Gage
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Christina R. Valauri
Ms. Christina R. Valauri
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Precipio Inc?
Os cinco principais acionistas de Precipio Inc são: Mr. Ilan S. Danieli
Quantas instituições possuem ações da Precipio Inc (PRPO)?
Em 2026Q1, 30 instituições possuíam ações da Precipio Inc, com valor de mercado aproximado de 341.74K, representando 19.15% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -28788.00.
Qual é a maior fonte de receita da Precipio Inc?
Em 2026Q1, o segmento de negócios Third party payers gerou a maior receita para Precipio Inc, totalizando 11.70M e representando 48.26% da receita total.